Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QVA149 vs Tiotropium and Placebo in Moderate to Severe COPD (BLAZE)
NCT01490125Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2011
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of indacaterol, glycopyrrolate metered dose inhaler in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started Oct 2011; status: completed.
02
Drugs
indacaterolglycopyrrolate metered dose inhaler
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01490125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01490125.